Monoclonal Antibody Therapy in Treating Patients With Brain Metastases

NCT00002751 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer

Interventions

BIOLOGICAL: monoclonal antibody Me1-14 F(ab')2

Sponsor

Duke University